TScan Therapeutics, Inc.
TCRX- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001783328
No open-market purchases or sales by TScan Therapeutics, Inc. insiders were filed in the last 90 days; 60 institutions reported holding it in 13F filings for Q2 2026, worth $35.1M in total; no superinvestor holds it.
13F holders, Q4 2023
Institutional positions in TScan Therapeutics, Inc. as of Dec 31, 2023. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 54
- +22 vs. Q3 2023
- Shares held
- 31.9M
- +3.32M (+11.6%) vs. Q3 2023
- Total value
- $186.1M
- +$112.9M (+154.2%) vs. Q3 2023
- New holders
- 22
- 12 more added
- Sold out
- 0
- 5 more reduced
Compare with Q3 2023: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting TCRX on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 60 | $35.1M |
| Q1 2026 | 60 | $32.8M |
| Q4 2025 | 61 | $30.7M |
| Q3 2025 | 73 | $62.9M |
| Q2 2025 | 81 | $51.8M |
| Q1 2025 | 92 | $55.4M |
| Q4 2024 | 89 | $126.2M |
| Q3 2024 | 89 | $208.3M |
| Q2 2024 | 81 | $242.6M |
| Q1 2024 | 66 | $272.3M |
| Q4 2023 | 54 | $186.1M |
| Q3 2023 | 32 | $73.2M |
| Q2 2023 | 28 | $69.9M |
| Q1 2023 | 28 | $20.3M |
| Q4 2022 | 28 | $14.8M |
| Q3 2022 | 26 | $29.0M |
| Q2 2022 | 24 | $30.4M |
| Q1 2022 | 25 | $26.3M |
| Q4 2021 | 29 | $44.4M |
| Q3 2021 | 27 | $83.5M |
| Q2 2021 | 0 | $0 |
| Q1 2021 | 0 | $0 |
Institutions, Q4 2023
Shares, value and share of portfolio for each institution holding TScan Therapeutics, Inc.; share changes are against Q3 2023.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Lynx1 Capital Management LP | 5,224,600 | $30.5M | 11.98% | 00.0% | Unchanged |
| EcoR1 Capital, LLC | 5,000,000 | $29.1M | 0.76% | 00.0% | Unchanged |
| Adage Capital Partners GP, L.L.C. | 3,900,000 | $22.7M | 0.05% | −100,000−2.5% | Reduced |
| BVF Inc | 2,989,474 | $17.4M | 0.44% | 00.0% | Unchanged |
| Baker Bros. Advisors LP | 2,784,792 | $16.2M | 0.18% | 00.0% | Unchanged |
| Propel Bio Management, LLC | 2,087,139 | $12.2M | 10.09% | +2,087,139 | New |
| Vanguard Group Inc | 1,788,152 | $10.4M | 0.00% | +35,558+2.0% | Added |
| BlackRock Inc. | 1,671,727 | $9.75M | 0.00% | −8,722−0.5% | Reduced |
| Deer Management Co. LLC | 1,245,505 | $7.26M | 0.94% | 00.0% | Unchanged |
| Alphabet Inc. | 1,077,080 | $6.28M | 0.29% | 00.0% | Unchanged |
| Simplify Asset Management Inc. | 1,046,916 | $6.10M | 0.95% | 00.0% | Unchanged |
| DC Funds, LP | 630,000 | $3.67M | 44.16% | 00.0% | Unchanged |
| Geode Capital Management, LLC | 391,646 | $2.28M | 0.00% | +83,708+27.2% | Added |
| Morgan Stanley | 234,703 | $1.37M | 0.00% | −24,744−9.5% | Reduced |
| Standard Life Aberdeen plc | 200,000 | $1.17M | 0.00% | +200,000 | New |
| Stifel Financial Corp | 120,400 | $701.9K | 0.00% | +3,500+3.0% | Added |
| Marshall Wace, LLP | 110,551 | $644.5K | 0.00% | +110,551 | New |
| Susquehanna International Group, LLP | 103,948 | $606.0K | 0.00% | +87,033+514.5% | Added |
| Millennium Management LLC | 99,082 | $577.6K | 0.00% | +99,082 | New |
| NewEdge Wealth, LLC | 91,463 | $533.2K | 0.01% | 00.0% | Unchanged |
| Bridgeway Capital Management, LLC | 88,300 | $514.8K | 0.01% | 00.0% | Unchanged |
| Jane Street Group, LLC | 83,622 | $487.5K | 0.00% | +83,622 | New |
| Qube Research & Technologies Ltd | 79,989 | $466.3K | 0.00% | +77,579+3,219.0% | Added |
| Citigroup Inc | 73,163 | $426.5K | 0.00% | +73,163 | New |
| Northern Trust Corp | 71,611 | $417.5K | 0.00% | −365−0.5% | Reduced |
| ExodusPoint Capital Management, LP | 63,778 | $372.0K | 0.00% | +63,778 | New |
| State Street Corp | 61,100 | $356.2K | 0.00% | +19,400+46.5% | Added |
| Laurion Capital Management LP | 60,400 | $352.1K | 0.01% | +60,400 | New |
| Man Group plc | 50,410 | $293.9K | 0.00% | +50,410 | New |
| Balyasny Asset Management LLC | 45,986 | $268.1K | 0.00% | +45,986 | New |
| 683 Capital Management, LLC | 43,198 | $251.8K | 0.03% | +43,198 | New |
| Bank of America Corp | 37,804 | $220.4K | 0.00% | +37,604+18,802.0% | Added |
| DC Investments Management, LLC | 35,563 | $207.3K | 0.21% | 00.0% | Unchanged |
| JPMorgan Chase & Co | 33,230 | $193.7K | 0.00% | +33,230 | New |
| Goldman Sachs Group Inc | 30,285 | $176.6K | 0.00% | +30,285 | New |
| Cubist Systematic Strategies, LLC | 26,245 | $153.0K | 0.00% | +26,245 | New |
| Charles Schwab Investment Management Inc | 22,104 | $128.9K | 0.00% | +22,104 | New |
| Renaissance Technologies LLC | 21,700 | $127.0K | 0.00% | +4,000+22.6% | Added |
| Pale Fire Capital SE | 21,573 | $125.8K | 0.02% | +4,998+30.2% | Added |
| American Century Companies Inc | 21,315 | $124.3K | 0.00% | +2,103+10.9% | Added |
| Letko, Brosseau & Associates Inc | 20,700 | $120.7K | 0.00% | −11,700−36.1% | Reduced |
| Virtu Financial LLC | 18,418 | $107.0K | 0.01% | +18,418 | New |
| Walleye Capital LLC | 17,777 | $103.6K | 0.00% | +17,777 | New |
| Bank of New York Mellon Corp | 16,670 | $97.2K | 0.00% | +16,670 | New |
| Privium Fund Management (UK) Ltd | 15,825 | $92.3K | 0.06% | 00.0% | Unchanged |
| Y-Intercept (Hong Kong) Ltd | 15,005 | $87.5K | 0.01% | +15,005 | New |
| Boothbay Fund Management, LLC | 13,293 | $77.5K | 0.00% | +13,293 | New |
| Aries Wealth Management | 10,000 | $58.3K | 0.02% | 00.0% | Unchanged |
| Waldron Private Wealth LLC | 10,000 | $58.3K | 0.00% | 00.0% | Unchanged |
| Lazard Asset Management LLC | 3,983 | $22.0K | 0.00% | +3,983 | New |
| UBS Group AG | 1,424 | $8.30K | 0.00% | +309+27.7% | Added |
| Atlas Capital Advisors LLC | 896 | $5.22K | 0.00% | 00.0% | Unchanged |
| Wells Fargo & Company | 301 | $1.75K | 0.00% | +15+5.2% | Added |
| Tower Research Capital LLC (TRC) | 43 | $251 | 0.00% | +43 | New |